載入...
Tau immunotherapies: Lessons learned, current status and future considerations
The majority of clinical trials targeting the tau protein in Alzheimer’s disease and other tauopathies are tau immunotherapies. Because tau pathology correlates better with the degree of dementia than amyloid-β lesions, targeting tau is likely to be more effective in improving cognition than clearin...
Na minha lista:
| 發表在: | Neuropharmacology |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492435/ https://ncbi.nlm.nih.gov/pubmed/32360477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2020.108104 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|